STOCK TITAN

Vivani Medical (VANI) Stock News, Jun 2023-Mar 2024

VANI NASDAQ

Vivani Medical, Inc. reports developments from a clinical-stage biopharmaceutical business focused on miniature, ultra long-acting subdermal drug implant candidates using its proprietary NanoPortal™ technology. News commonly centers on financial results, business updates, manufacturing and clinical-development spending, and progress for semaglutide-based implant candidates such as NPM-139 for chronic weight management and NPM-133 for type 2 diabetes.

The company’s updates also cover Cortigent, its wholly owned subsidiary developing brain implant devices based on precision neurostimulation technology. Cortigent disclosures include the Orion® Visual Cortical Prosthesis System, a cortical stimulation system under development to provide visual perception for blind persons, as well as equity financings, registered direct offerings, private placements, shareholder matters and governance updates.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.79%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-26.78%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
270.30%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.27%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.00%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.09%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.30%
Tags
conferences clinical trial
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.66%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.85%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.18%
Tags
conferences

FAQ

What is the current stock price of Vivani Medical (VANI)?

Vivani Medical (VANI) last closed at $1.05.

What is the market cap of Vivani Medical (VANI)?

The market cap of Vivani Medical (VANI) is approximately $94.7M.